Sublimity Therapeutics' Unattributed VC Round

Sublimity Therapeutics raised a round of funding on May 23, 2018.

Sublimity Therapeutics, formerly Sigmoid Pharma, operates as a biopharmaceutical company which develops orally administered pharmaceutical products in the areas of transplantation, gastro-intestinal d…

Articles about Sublimity Therapeutics' Unattributed VC Round: